Hypertension Education: An Important and Neglected Part of the Diabetes Education Curriculum?

The Diabetes Educator

Volumn 23, Issue 2, 1997, Pages 166-170

  Hinson, Janet ^a   Riordan, Kathy ^a   Hemphill, Donna ^a   Randolph, Carol ^a   Fonseca, Vivian ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CURRICULUM; DIABETES MELLITUS; EDUCATIONAL MODEL; HUMAN; HYPERTENSION; LIFESTYLE; PATIENT CARE; PATIENT EDUCATION; PREVALENCE;

ANTIHYPERTENSIVE AGENTS; CURRICULUM; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; LIFE STYLE; MODELS, EDUCATIONAL; PATIENT CARE TEAM; PATIENT EDUCATION; PREVALENCE;

EID: 0031090089     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572179702300207     Document Type: Article

References (36)

1. Reaven GM 1988 Banting lecture role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Ebstein M., Sowers JR Diabetes mellitus and hypertension. Hypertension. 1992:19:403-18.
3. Parving HH Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care. 1991;14:260-69.
4. Stamler J., Vaccaro O., Neaton JD, Wentworth D. Diabetes, other risk factors. and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-44.
5. Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke, and coronary heart diseases. II. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-38.
6. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in “mild” hypertension; results of the Hypertension Detection and Follow-up Program. N Engl J Med. 1982;307:976-80.
7. American Diabetes Association. Treatment of hypertension in diabetes. Diabetes Care. 1993;16:1394-1401.
8. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 1993, 153:184-83.
9. Tarnow L., Rossing P., Gall MA, Nielsen FS, Parving HH Prevalence of arterial hypertension in diabetic patients before and after the JNC -V. Diabetes Care. 1994:17:1247-51.
10. Sowers JR, Khoury S. Standley P, Zemel P., Zemel M. Mechanisms of hypertension in diabetes. Am J Hypertension. 1991;4:177-82.
11. Lewis E., Hunsicker L., Bain R., Rhode R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-62.
12. Marre M., Chatellier G., Leblanc H., Guyenne TT, Menard J., Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria Br Med J. 1988 ;297:1092-95.
13. Mathiesen ER, Hommel E., Giese J., Parving HH Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. Br Med J. 1991;303:81-87.
14. Parving HH, Hommel E., Nielsen MD, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin-dependent diabetics with nephropathy. Br Med J. 1989;299:533-36.
15. Borch-Johnson K., Wenzel H., Viberti GC, Mogensen CE Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes? Br Med J. 1993;306:1722-23.
16. Barnett AH Diabetes and hypertension. Br Med Bull. 1994 ;50:397-407.
17. Stein PP, Black HR Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care. 1991;14:425-48.
18. Maki DD, Ma JZ, Louis TA, Kasiske BL Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med. 1995;155:1073-80.
19. The Treatment of Mild Hypertension Research Group. The treatment of mild hypertension study: a random placebo-controlled trial of a nutritional hygienic regimen along with various drug monotherapies.Arch Intern Med. 1991;151:1413-23.
20. Stamler R., Stamler J., Grimm PH Nutritional therapy for high blood pressure ; final results of a four-year randomized controlled trial—the Hypertension Control Program. JAMA. 1987;257:1484-91.
21. Nothwehr F., Elmer P., Hannan P. Prevalence of health behaviors related to hypertension in three blood pressure treatment groups: the Minnesota Heart Health Program. Prev Med. 1994;23:362-68.
22. Elmer PJ, Grimm R. Jr., Laing B., et al. Lifestyle intervention: rcsults in the Treatment of Mild Hypertension Study (TOMHS). Prev Med. 1995;24: 378-88.
23. Woollard J., Beilin L., Lord T., Puddey I., Mac Adam D., Rouse I. A controlled trial of nurse counseling on lifestyle change for hypertensives treated in general practice: preliminary results. Clin Exp Pharmacol Physiol. 1995;22:466-68.
24. McDougall J., Litzau K., Haver E., Saunders V., Spiller GA Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat. strictly vegetarian diet. J Am Coll Nutr. 1995,14(5):491-96.
25. Nilsson PM, Lindholm LH, Schersten BF Lifestyle changes improve insulin resistance in hyperinsulinaemic subjects: a one-year intervention study of hypertensives and normotensives in Dalby. J Hypertension. 1992;10(9): 1071-78.
26. Perez-Stable EJ, Coates TJ, Baron RB, et al. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. J Gen Intern Med. 1995;10:419-28.
27. Goebel M., Viol GW, Orebaugh C. An incremental modcl to isolate specific effects of behavioral treatments in essential hypertension. Biofeedback Self Regul. 1993;18:255-80.
28. Anonymous. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention. JAMA. 1992;267:1213-20.
29. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
30. Schultz JF, Sheps SG Management of patients with hypertension: a hypertension clinic model. Mayo Clin Proc. 1994;69:997-99.
31. Reeves RA Does this patient have hypertension? How to measure blood pressure. JAMA. 1995;273:1211-17.
32. Weigmann TB, Herron KG, Chonko AM, Mac Dougall ML, Moore WV Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type-I diabetes mellitus. Diabetes. 1990;39:1556-60.
33. Sheps SG, Canzanello VJ Current role of automated ambulatory blood pressure and self-measured blood pressure determinations in clinical practice. Mayo Clin Proc. 1994;69:1000-5.
34. Nash CA Ensuring the accuracy of digital sphygmomanometers for home use. Mayo Clin Proc. 1994;69:1006-10.
35. Burt VL, Whelton P., Rocell EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-13.
36. National High Blood Pressure Education Program. Working group report on primary prevention of hypertension. Bethesda, Md: National Institutes of Health, 1993; NIH publication no. 93-2669.